结核病与肺部健康杂志 ›› 2019, Vol. 8 ›› Issue (2): 121-126.doi: 10.3969/j.issn.2095-3755.2019.02.010

• 论著 • 上一篇    下一篇

不同方法检测利福平耐药结核病及MTBrpoB基因突变的对比分析

林勇明1(),黄晓伟2,林淑芳1,魏淑贞1,林建1,赵永1   

  1. 1. 350000 福州,福建省疾病预防控制中心结核病防治科
    2. 福建省泉州市疾病预防控制中心结核病防治科
  • 收稿日期:2019-04-02 出版日期:2019-06-30 发布日期:2019-07-10
  • 基金资助:
    福建省卫生计生中青年骨干人才培养项目(2016-ZQN-21)

Analysis of detection of rifampicin-resistant tuberculosis and rpoB gene mutation by using different methods

Yong-ming LIN1(),Xiao-wei HUANG2,Shu-fang LIN1,Shu-zhen WEI1,Jian LIN1,Yong ZHAO1   

  1. 1. TB Control and Prevention Department of Fujian Provincial Center for Disease Control and Prevention, Fuzhou 350000, China
  • Received:2019-04-02 Online:2019-06-30 Published:2019-07-10

摘要:

目的 探讨不同方法检测利福平耐药结核病的效能,并分析利福平耐药MTB菌株ropB基因突变情况。方法 搜集2017年福建省泉州市下属10个县(市、区)结核病定点医院登记的同时经固体比例法药物敏感性试验(简称“比例法药敏试验”)、核酸反向线性探针杂交技术(属于GenoType MTBDRplus方法,简称“MTBDRplus”)与利福平耐药实时荧光定量核酸扩增检测技术(GeneXpert MTB/RIF,简称“Xpert技术”)等3种方法检测的511例确诊肺结核患者对利福平的耐药情况,并对3种方法检测结果不相同但至少1种结果为利福平耐药的66株MTB菌株行ropB基因测序,分析55株获得rpoB基因序列菌株的ropB基因突变情况。结果 511例检测患者中,比例法药敏试验、MTBDRplus和Xpert检测到利福平的耐药率分别为38.16%(195/511)、40.51%(207/511)和45.99%(235/511),MTBDRplus技术检测的利福平耐药率与比例法差异无统计学意义(χ 2=0.590,P=0.442),而Xpert技术检测利福平耐药率明显高于比例法(χ 2=6.424,P=0.011)。以比例法药敏试验检测结果为标准,Xpert技术和MTBDRplus检测MTB菌株对利福平耐药的敏感度、特异度、一致率分别为93.85%(183/195)和95.38%(186/195)、83.54%(264/316)和93.35%(295/316)、87.48%(447/511)和94.13%(481/511)。获得rpoB基因序列的55株菌株中,47株(85.46%)ropB基因在371~566位点间的17个位置发生了36种类型的突变;其中13株(23.64%)发生碱基缺失或插入,7株(12.73%)发生点突变,27株(49.09%)发生联合突变。45株(81.82%,45/55)为比例法检测利福平敏感而分子药敏试验检测耐药[包括14株(25.45%,14/55) MTBDRplus与Xpert检测对利福平均耐药的菌株、30株(54.55%,30/55) MTBDRplus检测对利福平敏感而Xpert检测为耐药、1株(1.82%,1/55) MTBDRplus检测对利福平耐药而Xpert检测为敏感的菌株],8株(14.55%,8/55)比例法药敏试验对利福平耐药而MTBDRplus与Xpert检测均敏感的菌株。MTBDRplus与Xpert检测对利福平耐药结果相同的菌株有22株,两者检测结果均耐药的14株菌株均发生ropB基因突变;而两者检测结果均敏感的8株菌株中,有6株菌株ropB基因发生突变。MTBDRplus与Xpert检测对利福平耐药结果不同的菌株有33株,其中31株为MTBDRplus检测敏感而Xpert检测为耐药。结论 分子药敏试验检测MTB利福平耐药性的敏感度较比例法药敏试验高。对利福平耐药菌株的ropB基因突变率较高,无论哪一种技术检测结果为利福平耐药,均应考虑该MTB对利福平耐药,应尽快应用其他检测方法进行验证。

关键词: 分枝杆菌, 结核, 利福平, 抗药性, 细菌, 微生物敏感性试验, 基因测定

Abstract:

Objective To explore the efficacy of different methods on detection of rifampicin-resistant tuberculosis (TB) and to analyze the situation of ropB gene mutation of rifampicin-resistant strains.Methods A total of 511 patients who had been notified as pulmonary TB in 10 county or district TB designated hospitals of Quanzhou City, Fujian Province in 2017, and received 3 kinds of tests as follows: drug susceptibility test with proportional method on solid media (proportional method), reverse linear probe hybridization (GenoType MTBDRplus method) and GeneXpert MTB/RIF (Xpert), were enrolled in this study and their situation of rifampicin resistance was collected. Among 511 TB patients, the ropB gene sequencing of 66 MTB strains with rifampicin resistance, which were detected by one of the 3 test methods at least, were conducted and the situation of the ropB gene mutations in 55 strains, which the sequence of rpoB gene were obtained, was analyzed.Results Among 511 strains tested, the rifampicin resistance rates detected by proportional method, MTBDRplus and Xpert were 38.16% (195/511), 40.51% (207/511) and 45.99% (235/511), respectively. There was no significant difference in rifampicin resistance rate between MTBDRplus technique and proportional method (χ 2=0.590, P=0.442), while it was significantly higher by Xpert technique than that of proportional method (χ 2=6.424, P=0.011). When the test result of proportional method was regarded at the standard, the sensitivity, specificity and consistency rates of Xpert and MTBDRplus to rifampicin resistance were 93.85% (183/195) and 95.39% (186/195), 83.54% (264/316) and 93.35% (295/316), 87.48% (447/511) and 94.13% (481/511), respectively. Among the 55 strains that their rpoB gene sequences were obtained, 36 types of mutation at 17 locations between 371 and 566 loci happened in the ropB gene of 47 strains (85.46%): 13 strains (23.64%) had base deletion or insertion, 7 strains (12.73%) had point mutation and 27 strains (49.09%) had joint mutation. Forty-five strains (81.82%, 45/55) were sensitive to rifampicin by proportional method but rifampicin resistance was detected by molecular susceptibility test (including 14 strains (34.15%, 14/55) of rifampicin resistance were detected by both MTBDRplus and Xpert, 30 strains (54.55%, 30/55) of rifampicin resistance were detected only by Xpert while MTBDRplus results were sensitive to rifampicin, 1 strain (1.82%, 1/55) of rifampicin resistance was detected by MTBDRplus only while Xpert result was sensitive to rifampicin, 8 strains (14.55%, 8/55) were resistant to rifampicin by proportional method but rifampicin sensitive by MTBDRplus and Xpert. The results of MTBDRplus and Xpert test were same in 22 strains, including 14 rifampicin resistant strains and 8 rifampicin sensitive strains; the ropB gene mutations were found in all 14 rifampicin resistant strains, but it happened in 6 strains out of 8 rifampicin sensitive strains. The difference examination results between MTBDRplus and Xpert, were found in 33 strains, of which 31 strains were rifampicin sensitive by MTBDRplus but rifampicin resistant by Xpert.Conclusion Molecular drug susceptibility test method is more sensitive than proportional method in detecting rifampicin resistance. The mutation rate of ropB gene in rifampicin-resistant strains is relatively high. Regardless of which techniques, if the results show rifampicin-resistance, rifampicin-resistant MTB should be considered and other examination methods should be used to confirm it as soon as possible.

Key words: Mycobacterium tuberculosis, Rifampin, Drug resistance, bacterial, Microbial sensitivity tests, Genetic testing